+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID07081945

Study of Human Amniotic Membrane Patch Use in Surgery for Inferior Rhegmatogenous Retinal Detachment

Led by Eye & ENT Hospital of Fudan University · Updated on 2025-07-28

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Rhegmatogenous retinal detachments RRDs with breaks in the lower part of the retina remain difficult to treat and have a higher risk of surgery not succeeding or the detachment coming back. Researchers are studying whether using human amniotic membrane hAM patches to cover these breaks during surgery can improve the chance of successfully reattaching the retina. This study will enroll 50 patients with these types of retinal detachments to test this method. Participants will receive a treatment called hAM patch-assisted vitrectomy, where surgeons place hAM patches over the breaks in the retina after removing the vitreous gel during surgery. This is a single-group study comparing results to previously reported outcomes in similar patients. The hAM patches are adjusted in size during surgery to fit the treatment needs. After surgery, patients will be followed for at least 6 months to assess how well the retina remains attached. During the study, researchers will monitor retinal reattachment and improvements in vision from the time of treatment through the 6-month follow-up. Patients will have examinations to evaluate these outcomes. The study aims to see if this approach reduces complications and improves surgical success. Overall participation lasts through at least 6 months after surgery, with careful tracking of visual and anatomical results.

CONDITIONS

Brief Title

hAM for Inferior RRD

Research Team

Z

Zhongcui Sun, PhD.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here